Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eray, Kirac"'
Autor:
Mustafa Adem Tatlisu, Adem Atici, Fatma Betul Ozcan, Mehmet Çelik, Eray Kirac, Omer Faruk Baycan, Mustafa Caliskan
Publikováno v:
Arquivos Brasileiros de Cardiologia (2022)
Resumo Fundamento O receptor fraco indutor de apoptose semelhante a fator de necrose tumoral solúvel (sTWEAK) é um membro da superfamília de TNF que tem um papel crítico na proliferação e inflamação na circulação arterial. Objetivos Este es
Externí odkaz:
https://doaj.org/article/5d582dc6d61e47bdb296542e3c6f9b89
Autor:
Mustafa Adem, Tatlisu, Adem, Atici, Fatma Betul, Ozcan, Mehmet, Çelik, Eray, Kirac, Omer Faruk, Baycan, Mustafa, Caliskan
Publikováno v:
Arquivos brasileiros de cardiologia. 119(3)
The soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) is a member of the TNF superfamily that plays a critical role in proliferation and inflammation in the arterial circulation.This prospective study aimed to show the relationshi
Autor:
Mustafa A. Tatlisu, Adem Atici, Fatma Betul Ozcan, Eray Kirac, Omer Faruk Baycan, Mustafa Caliskan
Publikováno v:
The American journal of the medical sciences. 364(5)
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is one of the inflammatory mediators contributing to the atherosclerotic process. TWEAK has been studied in patients with chronic kidney disease (CKD), and it has demonstrated that its
Abstract 14801: Can Plasma Tweak Predict Coronary Slow Flow in Patients With Chronic Kidney Disease?
Autor:
Omer Faruk Baycan, Fatma Betul Ozcan, Adem Atici, Mustafa Adem Tatlisu, Mustafa Caliskan, Eray Kirac
Publikováno v:
Circulation. 142
Introduction: The tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is one of the inflammatory mediators contributing to the atherosclerotic process. TWEAK has been studied in chronic kidney disease (CKD) patients and it has been shown tha